An oil-control composition containing medicinal pore fungus and having intelligent sebum regulation ability
By using a combination of ingredients such as medicinal Fomitopsis thaliana to promote microRNA-29 expression and activate the negative feedback mechanism of lipid metabolism, this solves the problem of rebound after discontinuation of existing oil-control products, and achieves the improvement of sebum self-regulation ability and skin moisturizing, repairing and anti-aging effects.
Patent Information
- Application Number
- CN202410513081.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-26
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-04-26
AI Technical Summary
Existing oil-control products neglect the important protective role of sebum on the skin barrier, resulting in sebum being unable to moisturize the skin, lock in moisture, and resist damage from the external environment. The effects are prone to rebound after discontinuing use, and they cannot improve skin quality from the root.
This product uses a combination of medicinal Fomitopsis, Camellia chrysantha flower extract, Spirulina powder, Chrysanthemum indicum extract, and Amomum villosum extract. By promoting the expression of microRNA-29, it activates the negative feedback mechanism of sebum metabolism, enhances the self-regulation ability of sebum, and combines moisturizing, repairing and anti-aging effects.
It enables the skin to quickly return to normal sebum secretion after the irritant disappears, and the effect does not rebound after discontinuation. It also has good moisturizing, repairing and anti-aging capabilities, and improves the skin texture of oily and sensitive skin.
Smart Images

Figure CN118384071B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of cosmetics, and in particular relates to an oil-control composition containing medicinal pore fungi and having an intelligent ability to enhance sebum regulation. Background Art
[0002] The skin secretes oil as a self-protective behavior, but excessive secretion can lead to clogged pores, acne, rough and dull skin. Healthy skin has the ability to self-regulate sebum secretion and can respond to environmental changes (such as ultraviolet rays, temperature, hormone levels, etc.) immediately. It can quickly restore normal oil secretion after the stimulus disappears, but oily and sensitive skin will overreact to stimuli and continue to secrete excessive oil after the stimulus disappears.
[0003] Existing oil control products blindly pursue the inhibition of sebum synthesis and secretion, ignoring the important protective role of sebum on the skin barrier, resulting in the inability of sebum to moisturize the skin, lock in moisture, and protect the skin from damage by the external environment, ultimately leading to problems such as dryness and desquamation, barrier damage, and accelerated aging; and there are no oil control products in the prior art that can enhance the self-regulating ability of sebum; therefore, if the existing oil control products are discontinued after use, the effect is likely to rebound, and the skin will still secrete excessive oil, i.e., the skin quality cannot be improved from the root. Summary of the invention
[0004] The purpose of the present invention is to overcome the deficiencies of the above-mentioned prior art and provide an oil control composition with excellent oil control effect, improving the self-regulation ability of sebum, and no rebound effect after discontinuation of use, and at the same time also having good moisturizing, repairing, firming skin, and anti-aging effects, which can intelligently enhance the sebum regulation ability.
[0005] To achieve the above-mentioned object, in a first aspect of the present invention, the present invention provides an oil control composition containing medicinal pore fungus for intelligently improving sebum regulation, wherein the oil control composition comprises component A and component B;
[0006] The component A comprises a medicinal phytomycetes extract, a golden camellia extract and spirulina powder;
[0007] The component B includes Hieracium officinale extract and Alpinia fasciata extract.
[0008] Studies have shown that microRNA-29 regulates the negative feedback regulation mechanism of oil metabolism, that is, while external stimuli promote oil secretion, excessive oil will in turn inhibit oil synthesis; the composition for intelligently improving sebum regulation provided by the present invention, by selecting suitable components for compounding, the obtained composition has an excellent effect of promoting microRNA-29 expression, thereby activating the negative feedback mechanism of oil metabolism, improving the self-regulation ability of sebum, and allowing the skin to quickly restore normal oil secretion after the stimulus disappears, and the effect does not rebound after discontinuation, thereby improving the skin quality of oily sensitive skin and solving the problem of excessive skin oil secretion from the root; at the same time, the composition provided by the present invention, by selecting the above-mentioned components to cooperate with each other, on the basis of achieving excellent oil control effect, also has good moisturizing, repairing, firming skin and anti-aging capabilities.
[0009] Specifically, the medicinal pore mushroom extract is a natural product extracted from the medicinal mushroom pore mushroom; it is rich in polysaccharides, polyphenols, proteins and other ingredients, and has antioxidant, anti-inflammatory, antibacterial and other biological activities; the golden camellia extract is rich in natural active ingredients, can absorb a large amount of moisture in the air and firmly lock the moisture without loss, and has a good moisturizing effect; the spirulina powder is obtained by grinding spirulina, is rich in protein and polysaccharides, has the effects of enhancing immunity, accelerating skin metabolism, and improving the problem of thick skin stratum corneum; the green-haired mountain willow extract can effectively treat dermatitis, has an inhibitory effect on induced allergies of the skin, can enhance the resistance of capillaries, and can eliminate free radicals at the same time, and also has a certain inhibitory effect on melanocytes; the cardamom extract is rich in chalcone compounds such as cardamomamine, which not only has significant antibacterial, anti-inflammatory and antioxidant effects, but also has whitening and anti-aging effects.
[0010] In one embodiment, the preparation method of the medicinal porphyra extract comprises the following steps: taking the medicinal porphyra dry powder and mixing it with water, heating and extracting it, then filtering it, collecting the filtrate and decolorizing it, centrifuging and filtering it after decolorization, collecting the filtrate and precipitating it with alcohol, collecting the supernatant, and obtaining the medicinal porphyra extract.
[0011] In one embodiment, the material-liquid ratio of the heating leaching is 1 g: (15-25) mL, the temperature is 90-110° C., and the time is 1.5-2.5 h; the decolorization temperature is 35-45° C.
[0012] In one embodiment, the preparation method of the Camellia chrysantha extract comprises the following steps: drying and crushing the Camellia chrysantha, mixing it with an ethanol-water solution, and then ultrasonically extracting it; then centrifuging and concentrating the supernatant; collecting the concentrated solution, and obtaining the Camellia chrysantha extract.
[0013] In one embodiment, the mass percentage of ethanol in the ethanol aqueous solution is 70-80%; the material-liquid ratio of ultrasonic extraction is 1g: (15-25)mL, the temperature is 35-45°C, the time is 25-35min, and the power is 60-100W.
[0014] In one embodiment, the preparation method of the Haworthia serrata extract comprises the following steps: drying and crushing the flowers of Haworthia serrata, mixing them with ethanol and aqueous solution, ultrasonically extracting them, then centrifuging and concentrating the supernatant, collecting the concentrated solution, and obtaining the Haworthia serrata extract.
[0015] In one embodiment, the mass percentage of ethanol in the ethanol aqueous solution is 70-80%; the material-liquid ratio of ultrasonic extraction is 1g: (15-25)mL, the temperature is 35-45°C, the time is 25-35min, and the power is 60-100W.
[0016] In one embodiment, the preparation method of the Alpinia phalloides extract comprises the following steps: taking dried mature seeds of Alpinia phalloides, crushing them, mixing them with ethanol and aqueous solution, and ultrasonically extracting them; then centrifuging and concentrating the supernatant; collecting the concentrated solution, and obtaining the Alpinia phalloides extract.
[0017] In one embodiment, the mass percentage of ethanol in the ethanol aqueous solution is 70-80%; the material-liquid ratio of ultrasonic extraction is 1g: (15-25)mL, the temperature is 35-45°C, the time is 25-35min, and the power is 60-100W.
[0018] As a preferred embodiment of the oil control composition of the present invention, in the oil control composition, the mass ratio of component A to component B is component A: component B = (2-20): (0.2-5).
[0019] Exemplarily, the mass ratio of component A to component B may be any point value or any two point range values between (2-20): (0.2-5), such as 2:0.2, 4:0.2, 6:0.2, 8:0.2, 10:0.2, 12:0.2, 14:0.2, 16:0.2, 18:0.2, 20:0.2, 2:1, 4:1, 6:1, 8:1, 10:1, 12:0.2, 14:1, 16:1, 18:1, 20:1, 2:2, 4:2, 6:2, 8:2, 10:2, 12:2, 14:2, 16:2, 18:2, 20:2, 2:3, 4:3, 6:3, 8:3, 10:3, 12:3, 14:3, 16:3, 18:3, 20:3, 2:4, 4:4, 6:4, 8:4, 10:4, 12:4, 14:4, 16:4, 18:4, 20:4, 2:5, 4:5, 6:5, 8:5, 10:5, 12:5, 14:5, 16:5, 18:5, 20:5, etc.
[0020] As a preferred embodiment of the oil control composition of the present invention, in the oil control composition, the mass ratio of component A to component B is component A: component B = (7-9): (1-2).
[0021] The present invention has found that the mass ratio of component A to component B in the oil control composition will affect the promoting effect of the oil control composition on microRNA-29 to a certain extent, thereby affecting the improvement effect of the oil control composition on the self-regulating ability of sebum, and further affecting whether a good oil secretion amount can be effectively maintained after discontinuation of use; at the same time, it will also have a certain impact on the actual oil control effect; when the mass ratio of component A to component B is further selected as (2-20): (0.2-5), especially (7-9): (1-2), the obtained oil control composition has a better oil control effect; and can enhance the promoting effect of the oil control composition on microRNA-29 to a greater extent; and can also improve the moisturizing, repairing, skin tightening and anti-aging abilities of the oil control composition to a certain extent.
[0022] As a preferred embodiment of the oil control composition of the present invention, in the component A, the mass ratio of the medicinal porphyra extract, the camellia chrysantha extract and the spirulina powder is: the medicinal porphyra extract: the camellia chrysantha extract: the spirulina powder = (1-5): (1-4): (1-4).
[0023] Exemplarily, the mass ratio of the medicinal pore fungus extract, the golden camellia extract and the spirulina powder can be any point value or any range value between (1-5): (1-4): (1-4), for example, 1:1:1, 1:1:2, 1:1:3, 1:1:4, 1:2:1, 1:2:2, 1:2:3, 1:2:4, 1:3:1, 1:3:2, 1:3 ...3:1, 1:3:2, 1:3:3, 1:1:4, 1:3:1, 1:3:2, 1:3:3, 1:1:4, 1:3:2 :3:4, 1:4:1, 1:4:2, 1:4:3, 1:4:4, 2:1:1, 2:1:2, 2:1:3, 2:1:4, 2:2:1, 2:2:2, 2:2:3, 2:2:4, 2:3:1, 2:3:2, 2:3:3, 2:3:4, 2:4:1, 2:4:2, 2:4:3, 2:4:4, 3:1:1, 3:1:2, 3 :1:3, 3:1:4, 3:2:1, 3:2:2, 3:2:3, 3:2:4, 3:3:1, 3:3:2, 3:3:3, 3:3:4, 3:4:1, 3:4:2, 3:4:3, 3:4:4, 4:1:1, 4:1:2, 4:1:3, 4:1:4, 4:2:1, 4:2:2, 4:2:3, 4:2:4, 4:3:1, 4:4:2 :3:2, 4:3:3, 4:3:4, 4:4:1, 4:4:2, 4:4:3, 4:4:4, 5:1:1, 5:1:2, 5:1:3, 5:1:4, 5:2:1, 5:2:2, 5:2:3, 5:2:4, 5:3:1, 5:3:2, 5:3:3, 5:3:4, 5:4:1, 5:4:2, 5:4:3, 5:4:4, etc.
[0024] As a preferred embodiment of the oil control composition of the present invention, in the component A, the mass ratio of the medicinal porphyra extract, the camellia chrysantha extract and the spirulina powder is: the medicinal porphyra extract: the camellia chrysantha extract: the spirulina powder = (3-5): (1-3): (1-3).
[0025] The present invention has found that the mass ratio of the components in component A will affect the improvement effect of the oil control composition on oil secretion to a certain extent, and will affect the promotion effect of the oil control composition on microRNA-29. When the mass ratio of the medicinal porphyra extract, the golden camellia extract and the spirulina powder in component A is further selected to be (1-5): (1-4): (1-4), especially (3-5): (1-3): (1-3), the obtained oil control composition has a better promotion effect on microRNA-29a, microRNA-29b and microRNA-29c, and is therefore less likely to rebound after discontinuation of use; and when the components in component A are within the above-mentioned further selected mass ratio range, the obtained oil control composition also has better moisturizing, repairing, skin tightening and anti-aging abilities.
[0026] As a preferred embodiment of the oil control composition of the present invention, in the component B, the mass ratio of the Hieracium sutchuenensis extract to the Alpinia fasciata extract is Hieracium sutchuenensis extract:Alpinia fasciata extract=(1-5):(1-2).
[0027] Exemplarily, the mass ratio of the Haworthia oxypetalum extract and the Alpinia oxypetalum extract can be any point value or any two point range values between (1-5): (1-2), such as 1:1, 1:2, 2:1, 2:2, 3:1, 3:2, 4:1, 4:2, 5:1, 5:2, etc.
[0028] As a preferred embodiment of the oil control composition of the present invention, in the component B, the mass ratio of the Haworthia scoparia extract to the Alpinia fasciata extract is Haworthia scoparia extract:Alpinia fasciata extract=(1-3):1.
[0029] The present invention has found that the selection of the mass ratio of the components in component B can affect the promotion of microRNA-29 to a certain extent, thereby affecting the effect of the oil control composition on the self-regulation ability of sebum, and further affecting the rebound effect after discontinuation of use; and the mass ratio of the components in component B will also affect the moisturizing, repairing, firming and anti-aging abilities of the oil control composition; when the mass ratio of the green willow chrysanthemum extract and the cardamom extract is further selected to be (1-5): (1-2), especially (1-3): 1, the obtained oil control composition has the best comprehensive effect.
[0030] As a preferred embodiment of the oil control composition of the present invention, the mesh size of the spirulina powder is 80-200 meshes.
[0031] The present invention has found that when the mesh size of spirulina powder is 80-200 meshes, it can be better mixed with other components and improve the subsequent preparation efficiency.
[0032] In a second aspect of the present invention, the present invention provides a method for preparing the oil control composition, which comprises the following steps: dissolving spirulina powder in deionized water and then adding the remaining components to mix to obtain the oil control composition.
[0033] The preparation method provided by the invention is simple to operate and is conducive to actual production.
[0034] As a preferred embodiment of the preparation method of the present invention, the mass volume ratio of the total mass of the composition to deionized water is (0.6-0.9) g / mL.
[0035] In the third aspect of the present invention, the present invention provides use of the oil control composition in preparing a product for promoting the expression of microRNA-29.
[0036] The oil control composition provided by the present invention can effectively promote the expression of microRNA-29, specifically, can promote the expression of microRNA-29a, microRNA-29b, and microRNA-29c, and can be used in the preparation of products that promote the expression of microRNA-29.
[0037] In a fourth aspect of the present invention, the present invention provides use of the oil control composition in preparing cosmetics.
[0038] The present invention has found that the oil control composition provided by the present invention can effectively promote the expression of microRNA-29, thereby enhancing the self-regulation ability of sebum. On the basis of achieving the basic oil control effect, there is no rebound after discontinuation of use; and the oil control composition provided by the present invention can also achieve certain moisturizing, repairing, firming skin and anti-aging effects; therefore, it can be used in the preparation of cosmetics.
[0039] As a preferred embodiment of the application of the present invention, the cosmetics include any one of lotion, emulsion, ointment, cream, mask, essence, and spray.
[0040] In a fifth aspect of the present invention, the present invention provides an oil control emulsion, comprising the oil control composition.
[0041] The oil-control emulsion provided by the present invention can achieve an excellent effect of controlling oil secretion by introducing an oil-control composition, and has the ability to control oil secretion for a long time after discontinuation of use, that is, it is not easy to rebound after discontinuation, which reflects the improvement of the excellent self-regulation ability of sebum; at the same time, the oil-control emulsion provided by the present invention has good moisturizing, repairing, skin firming and anti-aging effects on the basis of the self-regulation ability of oil and sebum.
[0042] As a preferred embodiment of the oil control emulsion of the present invention, the oil control emulsion comprises the following components in percentage by mass: 10-25% of the oil control composition, 1-15% of the cosmetic base, and the balance of deionized water.
[0043] The present invention has found that when the mass percentage of the oil control composition is further selected to be 10-25%, a good comprehensive effect can be achieved.
[0044] As a preferred embodiment of the oil-control emulsion of the present invention, the cosmetic matrix includes at least one of a thickener, a moisturizer, a pH adjuster, an emulsifier, and a preservative.
[0045] As a preferred embodiment of the oil control emulsion of the present invention, at least one of the following (a)-(e) is included:
[0046] (a) the thickener comprises at least one of xanthan gum, carbomer, hydroxyethyl acrylate / sodium acryloyldimethyl taurate copolymer, ammonium acryloyldimethyl taurate / VP copolymer, sclerotium gum, and cetyl alcohol;
[0047] (b) the moisturizing agent comprises at least one of allantoin, sodium polyacrylate, hydrogenated lecithin, betaine, β-glucan, trehalose, caprylyl glycol, dipropylene glycol, sodium hyaluronate, 1,2-butylene glycol, glycerol, budding septin polysaccharide, and ceramide;
[0048] (c) the pH adjusting agent comprises at least one of arginine, tromethamine, and EDTA-disodium;
[0049] (d) the emulsifier comprises at least one of caprylic capric triglyceride, C14-22 alcohol, C12-20 alkyl glucoside, cetearyl glucoside, isononyl isononanoate, pentaerythritol tetrastearate, polydimethylsiloxane, stearyl alcohol, hydroxystearic acid, polymethylsilsesquioxane, pentaerythritol distearate, and sucrose stearate;
[0050] (e) The preservative includes at least one of 1,2-propylene glycol, 1,2-hexanediol, p-hydroxyacetophenone, and acrylates / C10-30 alkyl acrylate cross-polymer.
[0051] In a sixth aspect of the present invention, the present invention provides a method for preparing the oil control emulsion, the preparation method comprising the following steps:
[0052] (1) Mixing a humectant, a thickener and part of a pH adjuster with water, stirring, heating to 80-90° C., homogenizing at a speed of 1000-1400 rpm for 3-5 minutes, and keeping warm for later use after homogenization to obtain a prefabricated component A;
[0053] (2) Mix the emulsifier, heat to 70-80° C., homogenize at 1000-1400 rpm for 3-5 min, and keep warm for later use to obtain prefabricated component B;
[0054] (3) Mix the preservatives and heat to 55-65° C. to melt to obtain a prefabricated C component;
[0055] (4) The preformed component A is heated to 75-85°C, and the preformed component B is added at a speed of 200-500 rpm, and stirred and mixed. Then, the temperature is lowered to 55-65°C, and the preformed component C is added at a speed of 200-500 rpm and stirred and mixed. Then, the temperature is lowered to below 45°C, and the composition is added and stirred for 5-10 minutes. Finally, the remaining pH adjuster is added to adjust the pH to 5.5-7.0, and the stirring can be stopped. The material is discharged to obtain an oil-control emulsion.
[0056] The emulsion preparation method provided by the invention is easy to operate, does not require any specific equipment, and is beneficial to actual production.
[0057] Compared with the prior art, the present invention has the following beneficial effects:
[0058] The oil control composition provided by the present invention has an excellent effect of promoting the expression of microRNA-29 after compounding by selecting the components of the appropriate types, so that the negative feedback mechanism of oil metabolism can be activated, the self-regulation ability of sebum can be improved, and the skin can quickly restore the normal oil secretion after the stimulus source disappears, and the effect does not rebound after discontinuation, thereby improving the skin quality of oily sensitive skin, and solving the problem of excessive oil secretion of the skin from the root; at the same time, the composition provided by the present invention cooperates with each other by selecting the above-mentioned components, and on the basis of achieving excellent oil control effect, it also has good moisturizing, repairing, and skin tightening ability; when applied to subsequent cosmetics such as the preparation of emulsions, the obtained emulsion has an excellent effect of controlling oil secretion, and can improve the conditions of excessive oil secretion of the skin, enlarged pores, dark skin, scales, and peeling; and after discontinuation, it can also maintain normal oil secretion for a long time, and it also has good moisturizing, repairing, and skin tightening effects. At the same time, the preparation method of the oil control composition and oil control emulsion provided by the present invention is simple and suitable for actual production. BRIEF DESCRIPTION OF THE DRAWINGS
[0059] Figure 1 This is a graph showing the results of the activity test of the oil control composition in Effect Example 2 on human sebaceous gland cells SZ95;
[0060] Figure 2 This is a graph showing the effect of the oil control composition on the relative content of neutral lipids in cells in Effect Example 2;
[0061] Figure 3 This is a graph showing the effect of the oil control composition on microRNA-29 gene expression in Effect Example 2;
[0062] Figure 4 This is a comparison chart of the volunteers who used the oil-control lotion prepared in Application Example 1 in Effect Example 3 and stopped using it. DETAILED DESCRIPTION
[0063] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.
[0064] Unless otherwise specified, the reagents, methods and equipment used in the present invention are all conventional reagents, methods and equipment in the art; and unless otherwise specified, the raw materials used in parallel experiments are from the same batch of raw materials.
[0065] The preparation method of the medicinal porphyra extract comprises the following steps: washing the medicinal porphyra and drying it in a 50°C constant temperature oven to constant weight, grinding and crushing it, passing it through an 80-mesh sieve, taking 1g, adding 20mL of distilled water, leaching at 100°C for 2h, repeating 3 times, and finally filtering the extract to remove the filter residue. Adding 1.5% activated carbon to the filtrate at 40°C for decolorization, removing the activated carbon by centrifugal filtration, precipitating with alcohol, standing for separation, and centrifuging to extract the supernatant to obtain the medicinal porphyra extract;
[0066] The preparation method of the camellia chrysantha extract comprises the following steps: collecting the flowers of the camellia chrysantha, cleaning them and drying them in a 50°C constant temperature oven to constant weight, grinding and crushing them and passing them through an 80-mesh sieve, taking 1g of them, adding 20mL of 75% ethanol by volume, performing ultrasonic extraction at 40°C for 30min at a power of 80W, extracting the supernatant by centrifugation, and concentrating them under reduced pressure to 5mL, thereby obtaining the camellia chrysantha extract;
[0067] Spirulina powder, trade name Peptide Noin TM , Qingdao Zhongke Lanzhi Biotechnology Co., Ltd.;
[0068] A preparation method of a hawkweed extract comprises the following steps: collecting flowers of the hawkweed, cleaning them, drying them in a 50°C constant temperature oven to constant weight, grinding them, passing them through an 80-mesh sieve, taking 1 g of the flowers, adding 20 mL of 75% ethanol by volume, performing ultrasonic extraction at 40°C for 30 min at a power of 80 W, extracting the supernatant by centrifugation, and concentrating the supernatant under reduced pressure to 5 mL, thereby obtaining the hawkweed extract;
[0069] The preparation method of the cardamom extract comprises the following steps: collecting dried mature seeds of the cardamom, grinding and crushing them, passing them through an 80-mesh sieve, taking 1 g, adding 20 mL of 75% ethanol by volume, performing ultrasonic extraction at 40°C for 30 min with a power of 80 W, extracting the supernatant by centrifugation, and concentrating under reduced pressure to 5 mL to obtain the cardamom extract.
[0070] Examples 1-11 and Comparative Examples 1-7
[0071] The examples and comparative examples of the present invention provide an oil control composition, and the components (parts by weight) of the oil control composition are shown in Table 1;
[0072] Table 1
[0073]
[0074]
[0075] The preparation method of the oil control composition provided in Example 1 is: mixing spirulina powder and deionized water to form a solution (the mass volume ratio of the total mass of the composition components to the deionized water is 0.8 g / mL), and then adding the remaining components and stirring and mixing evenly to obtain the oil control composition.
[0076] The preparation methods of the oil control compositions provided in Examples 2-11 and Comparative Examples 1-7 are consistent with the method in Example 1, and if there are no related components, no relevant components are added.
[0077] Comparative Example 8
[0078] The comparative example of the present invention provides an oil control composition, the only difference between the oil control composition and Example 1 is that the camellia extract (the extraction process is consistent with that of the camellia chrysantha extract) is used to replace the camellia chrysantha extract.
[0079] Comparative Example 9
[0080] The comparative example of the present invention provides an oil control composition, the only difference between the oil control composition and Example 1 is that the cardamom extract (the extraction process is consistent with that of the cardamom extract) is used to replace the cardamom extract.
[0081] Application examples 1-12, comparative application examples 1-9 and blank application examples
[0082] Application Examples 1-12, Comparative Application Examples 1-9 and Blank Application Examples of the present invention provide an oil control emulsion, the components (mass percentage) of the oil control emulsion are shown in Table 2; wherein the oil control compositions in Application Examples 1-11 are respectively the oil control compositions prepared in Examples 1-11, and the oil control compositions in Comparative Application Examples 1-9 are respectively the oil control compositions prepared in Comparative Examples 1-9; for example, the oil control composition used in Application Example 6 is the oil control composition prepared in Example 6, and the same applies to the others; the oil control composition used in Application Example 12 is the oil control composition prepared in Example 1;
[0083] Table 2
[0084]
[0085] The preparation method of the emulsion provided in Application Example 1 comprises the following steps:
[0086] (1) Mixing a humectant, a thickener and part of a pH adjuster with water, heating to 85±2° C., homogenizing at a speed of 1200 rpm for 4 minutes, and keeping the mixture warm for later use to obtain a prefabricated component A;
[0087] (2) Mix the emulsifier, heat to 85±2° C., homogenize at 1200 rpm for 4 min, and keep warm for later use to obtain prefabricated component B;
[0088] (3) Mix the preservatives and heat to 60±2°C to melt to obtain a prefabricated C component;
[0089] (4) The preformed component A is heated to 80±2°C, and the preformed component B is added at a speed of 350 rpm, and stirred and mixed. Then, the temperature is lowered to 60±2°C, and the preformed component C is added at a speed of 350 rpm and stirred and mixed. Then, the temperature is lowered to 40°C, and the composition is added and stirred for 8 minutes. Finally, the remaining pH adjuster is added to adjust the pH to 6.0, and the stirring can be stopped. The material is discharged to obtain an oil-control emulsion.
[0090] Effect Example 1
[0091] The effect examples of the present invention verify the promoting effect of the oil control composition provided by Examples 1-11 and Comparative Examples 1-9 on the expression of microRNA-29 and the ability to inhibit oil synthesis and secretion, specifically including the following aspects:
[0092] 1. Solution configuration:
[0093] Preparation of test samples: Take 0.10 mL of the sample of each embodiment and comparative example, add 0.90 mL of sodium pyruvate-free DMEM (Gibco, C11965500BT) culture medium to prepare a mother solution with a concentration of 10%;
[0094] Preparation of hydrocortisone solution: weigh 0.01 g of hydrocortisone (Shanghai Yuanye Biotechnology, S31360) and add 1 mL of methanol to prepare a 10 mg / mL stock solution;
[0095] Preparation of isotretinoin solution: weigh 0.01 g of isotretinoin (Shanghai Dibai Biotechnology, H573005), add 1 mL of methanol to prepare a 10 mg / mL stock solution;
[0096] Culture medium: Take 10 mL of fetal bovine serum (FBS) (Macklin, F917980) and add 90 mL of DMEM culture medium to prepare a sodium pyruvate-free DMEM culture medium containing 10% FBS;
[0097] Maintenance medium: Take 1 mL of fetal bovine serum (FBS) and add 99 mL of DMEM culture medium to prepare a sodium pyruvate-free DMEM medium containing 1% FBS;
[0098] PBS buffer: purchased from Gibco, product number C10010500BT.
[0099] 2. Experimental groups:
[0100] Negative control group (NT): maintenance medium;
[0101] Model group (M): maintenance medium + 10 ng / mL hydrocortisone;
[0102] Positive control group (PC): 0.01 mM isotretinoin + maintenance medium + 10 ng / mL hydrocortisone;
[0103] Sample group (TA): 0.27% sample + maintenance medium + 10 ng / mL hydrocortisone;
[0104] 3. Specific process:
[0105] The cell line used was human sebaceous gland cell SZ95 (Shanghai Qingqi Biotechnology, BFN60807569), with a passage number of 7. The test conditions were: incubator temperature 37±1°C, humidity 90±5%, carbon dioxide 5±1%; cell culture was performed according to grouping, followed by testing. The specific tests were neutral lipid fluorescence quantitative experiment and microRNA-29 gene expression detection. The test methods were as follows:
[0106] Neutral lipid fluorescence quantification experiment:
[0107] (1) The cell suspension was inoculated into a 96-well cell culture plate (black bottom transparent type) with a density of 1.0*10 4 100 μL of culture medium was added to each well and cultured for 18-24 h.
[0108] (2) The supernatant was discarded, and 100 μL of maintenance medium was added to the negative control group, 100 μL of maintenance medium containing 10 ng / mL hydrocortisone was added to the model group, 100 μL of maintenance medium containing 10 ng / mL hydrocortisone and 0.01 mM isotretinoin was added to the positive control group, and 100 μL of maintenance medium containing 10 ng / mL hydrocortisone and 0.27% sample was added to the sample group;
[0109] (3) After incubation for 48 h, the supernatant was discarded, and the cells were washed twice with PBS. 100 μL of 10 μg / mL Nile red dye (Shanghai Yuanye Biotechnology, S02N11G129713) was added to the sample group, and 15 ng / mL of fluorescein diacetate FDA (Shanghai Yuanye Biotechnology, J22A11H122040) was added to the model group. The cells were incubated for 5 min, and the released fluorescence was detected on a multifunctional microplate reader. Excitation wavelengths of 485 nm and 494 nm and absorption wavelengths of 565 nm and 523 nm were used to detect the fluorescence intensity of Nile red and FDA, respectively;
[0110] (4) The results were determined by the ratio of Nile red and FDA (OD ratio), and the percentage of intracellular neutral lipids (%) = OD ratio of the control group or sample group / OD ratio of the model group*100%.
[0111] MicroRNA-29 gene expression detection:
[0112] Real-time fluorescence quantitative PCR was used to detect the expression of microRNA-29a, microRNA-29b, and microRNA-29c genes in the human sebaceous gland cells of the above groups, using U6 as an internal reference gene. The primer sequences used are shown in Table 3.
[0113] Table 3
[0114]
[0115]
[0116] In this test, the improvement of oil secretion is expressed by the improvement rate of each value, and the calculation method is as follows:
[0117] Improvement rate of oil secretion = (neutral lipid percentage M - Neutral lipid percentage TA ) / (neutral lipid percentage M - Neutral lipid percentage NT )×100%;
[0118] microRNA-29 promotion rate = (microRNA-29 expression TA / microRNA-29 expression M -1)×100%;
[0119] The calculated results are shown in Table 4;
[0120] Table 4
[0121]
[0122] As can be seen from Table 4, the oil control composition prepared by the technical solution of the present invention has an excellent effect of improving oil secretion and can effectively promote the expression of microRNA-29; specifically, the oil secretion improvement rate is more than 43%, and the expression promotion rates of microRNA-29a, microRNA-29b, and microRNA-29c are more than 56%, more than 118%, and more than 99%, respectively;
[0123] It can be seen from Examples 1-5 that the mass ratio of component A and component B in the oil control composition will affect the oil control ability of the product and the promotion effect on the expression of microRNA-29. When the mass ratio of component A to component B is further selected as (7-9): (1-2), the comprehensive effect of the obtained oil control composition is better, the oil secretion improvement rate is more than 92%, and the expression promotion rates of microRNA-29a, microRNA-29b, and microRNA-29c are more than 95%, more than 204%, and more than 239%, respectively. It can be seen from Examples 1, 6-8 that the mass ratio of the medicinal porphyra extract, the golden camellia extract, and the spirulina powder in component A will also affect the oil control ability of the product and the promotion effect of microRNA-29 expression. When the mass ratio of the medicinal porphyra extract, the golden camellia extract, and the spirulina powder is further selected as (3-5): (1-3): ( 1-3), the comprehensive effect of the obtained oil control composition is better, the oil secretion improvement rate is more than 92%, and the expression promotion rates of microRNA-29a, microRNA-29b, and microRNA-29c are more than 95%, more than 204%, and more than 240%, respectively; It can be seen from Example 1 and Examples 9-11 that the mass ratio of the green hairy willow chrysanthemum extract and the cardamom extract in component B will also affect the oil control ability of the product and the microRNA-29 expression promotion effect. When the mass ratio of the green hairy willow chrysanthemum extract and the cardamom extract is further selected as (1-3): 1, the comprehensive effect of the obtained oil control composition is better, the oil secretion improvement rate is more than 93%, and the expression promotion rates of microRNA-29a, microRNA-29b, and microRNA-29c are more than 96%, more than 203%, and more than 240%, respectively;
[0124] It can be seen from Example 1 and Comparative Examples 1-7 that whether component A or component B is missing, or any one of component A and component B, the effect of the present invention cannot be achieved. Compared with Example 1, the improvement rate of oil secretion of the products obtained in Comparative Examples 1-7 decreased by 83-94%, and the promotion rates of the expression of microRNA-29a, microRNA-29b, and microRNA-29c decreased by 84-101%, 175-207%, and 205-241%, respectively; It can be seen from Example 1 and Comparative Examples 8-9 that when other types of components are used to replace the components in the present invention, the corresponding effects cannot be achieved;
[0125] In addition, the results of the activity test of the oil control composition prepared in Example 1 of the present invention on human sebaceous gland cells SZ95 at a concentration of 0-21.87% are as follows: Figure 1 As shown, from Figure 1It can be seen that the oil control composition provided by the present invention has no significant effect on the activity of sebaceous gland cells SZ95 within a concentration range of 0-0.27%;
[0126] In addition, the oil control composition prepared in Example 1 of the present invention was tested for oil secretion and microRNA-29 expression promotion at a concentration of 0.09-0.27%. The results are as follows: Figure 2 and Figure 3 As shown, from Figure 2 It can be seen from the above that the oil control composition provided by the present invention can significantly inhibit the excessive oil secretion induced by hydrocortisone; Figure 3 It can be seen that the oil control composition provided by the present invention can effectively promote the expression of microRNA-29a, microRNA-29b, and microRNA-29c;
[0127] in, Figure 1-3 In the table, * indicates that the difference was statistically significant (P<0.05) compared with the model group (M), and # indicates that the difference was statistically significant (P<0.05) compared with the negative control group (NT).
[0128] Effect Example 2
[0129] The effect examples of the present invention verify the safety of the oil control emulsions prepared by application examples 1-12 and comparative application examples 1-9, and the human skin patch test is used for testing, which specifically includes the following steps:
[0130] 30 volunteers were recruited, 15 males and 15 females, aged 20-50 years old, and the closed patch test method was used. An equal amount (0.020mL-0.025mL) of the test sample (the oil-control lotion prepared in Application Examples 1-12 and Comparative Application Examples 1-9) was placed in a specific patch tester, and it was applied to the volunteer's arm with a low-allergenic tape, and gently pressed to evenly apply it on the skin, and left for 24 hours; the blank control group was distilled water, and the blank application example was a lotion without an oil-control composition. After 24 hours, the patch tester was removed, and the skin reaction was observed after 0.5 hours, 24 hours, and 48 hours, and the results were recorded; the level of adverse reactions to the skin is shown in Table 5;
[0131] Table 5
[0132]
[0133] After testing, the oil-control emulsions prepared in Application Examples 1-12 of the present invention and Comparative Application Examples 1-9 all showed negative reactions after human patch tests, and they are safe and non-irritating to human skin.
[0134] Effect Example 3
[0135] The effect examples of the present invention verify the efficacy of the oil control emulsion prepared by application examples 1-12, comparative application examples 1-9 and blank application examples in improving the self-regulation ability of sebum, and specifically include the following steps:
[0136] According to the "Technical Specifications for Safety of Cosmetics" (2015), 132 Asian adult testers aged 18-60 with oily and sensitive skin were selected and randomly divided into 22 groups, with 6 people in each group. The volunteers used samples (the samples were the oil-control lotions prepared in Application Examples 1-12, Comparative Application Examples 1-9 and Blank Application Examples) on their entire faces once in the morning and evening every day, and visited to collect data on the 0th day, 7th day, 14th day, and 1 week after stopping use. On the day of the volunteer's visit, the skin oil test probe (Sebumeter SM 815) was used to collect the 0h zygomatic oil content data (T0), and then the volunteer washed his face with a soap-based facial cleanser, and collected the zygomatic oil content data (T1) after sitting in an air-conditioned room at a temperature of 21±1℃ and a humidity of 50±10% for 2 hours. In this experiment, the improvement of the sebum self-regulation ability is represented by the improvement rate of each value, and the calculation method is as follows:
[0137] Sebum self-regulation ability change rate A = (T1-T0) 第X天 / (T1-T0) 第0天 ;
[0138] The improvement rate of the sebum self-regulation ability of the sample = (A sample - A blank application example) × 100%;
[0139] The results obtained are shown in Table 6;
[0140] Table 6
[0141]
[0142] As can be seen from Table 6, the oil-control emulsion prepared by the technical solution of the present invention has an excellent improvement rate of sebum self-regulation ability; specifically, the improvement rates of sebum self-regulation ability after 7 days, 14 days, and one week of discontinuation are above 12%, above 28%, and above 20%, respectively;
[0143] It can be seen from Application Examples 1-5 that the mass fractions of component A and component B in the oil control composition will affect the sebum self-regulating ability of the oil control lotion. When the mass ratio of component A to component B is further selected as (7-9): (1-2), the comprehensive effect of the obtained oil control lotion is better, and the improvement rates of sebum self-regulating ability after 7 days, 14 days, and one week of non-use are more than 38%, more than 58%, and more than 43%, respectively. It can be seen from Application Examples 1, 6-8 that the mass ratio of the medicinal porphyra extract, the golden camellia extract, and the spirulina powder in component A will also affect the product. When the mass ratio of the medicinal porphyra extract, the golden camellia extract, and the spirulina powder is further selected as (7-9): (1-2), the comprehensive effect of the obtained oil control lotion is better, and the improvement rates of sebum self-regulating ability after 7 days, 14 days, and non-use for one week are more than 38%, more than 58%, and more than 43%, respectively. When the mass ratio of the green-haired hawkweed extract and the cardamom extract in component B is (3-5): (1-3): (1-3), the comprehensive effect of the obtained oil-control lotion is better, and the improvement rates of the sebum self-regulation ability after 7 days, 14 days and one week of discontinuation are respectively more than 37%, more than 55%, and more than 44%. It can be seen from Application Examples 1 and 9-11 that the mass ratio of the green-haired hawkweed extract and the cardamom extract in component B will also affect the product. When the mass ratio of the green-haired hawkweed extract and the cardamom extract is further selected as (1-3): 1, the comprehensive effect of the obtained oil-control lotion is better, and the improvement rates of the sebum self-regulation ability after 7 days, 14 days and one week of discontinuation are respectively more than 36%, more than 60%, and more than 45%.
[0144] It can be seen from Application Example 1 and Comparative Application Examples 1-7 that no matter component A or component B is missing, or any one of component A and component B is missing, the effect of the present invention cannot be achieved. Compared with Application Example 1, the improvement rates of sebum self-regulation ability of the products obtained in Comparative Application Examples 1-7 decreased by 31-46%, 48-66%, and 48-55% after 7 days, 14 days, and one week of non-use, respectively; it can be seen from Application Example 1 and Comparative Application Examples 8-9 that when other similar components replace the components in the oil control composition, the obtained emulsion cannot achieve the effect of the present invention.
[0145] in addition, Figure 4 Comparison diagrams of a volunteer using the oil-control lotion prepared in Application Example 1 of the present invention before use, on the 7th day of use, on the 14th day of use, and after one week of discontinuation are shown. Specifically, facial images of the volunteer at each time point were collected after washing his face and sitting for 2 hours. Figure 4 It can be seen that the oil-control lotion provided by the present invention can significantly improve the self-regulation ability of sebum, and the effect does not rebound after discontinuation of use.
[0146] Effect Example 4
[0147] The effect example of the present invention verifies the moisturizing, repairing and skin tightening effects of the oil control emulsion prepared in application examples 1-12 and blank application examples, and specifically comprises the following steps:
[0148] According to the "Technical Specifications for Safety of Cosmetics" (2015), 78 Asian adult testers aged 18-60 with oily and sensitive skin were selected and randomly divided into 13 groups, with 6 people in each group. The volunteers used samples (the samples were the oil-control lotions prepared in Application Examples 1-12 and Blank Application Examples) on their entire faces once in the morning and evening every day, and data were collected on the 0th day of use, the 28th day, and one week after discontinuation of use. On the day of the volunteer's visit, the volunteer washed his face in the test area without applying any product, and sat quietly in an air-conditioned room with a temperature of 21±1℃ and a humidity of 50±10% for 20 minutes. Use a skin moisture loss test probe ( The transepidermal water loss (TEWL) of the zygomatic area was measured using the TM Hex, the skin firmness parameter F4 was measured using the elasticity tester Cutometer (MPA580, Courage and Khazaka, Germany), and facial wrinkles were photographed and analyzed using VISIA-CR.
[0149] The skin barrier moisturizing and repairing ability is represented by the improvement of TEWL value, the firming ability is represented by the improvement of F4, and the anti-wrinkle ability is represented by the improvement of the wrinkle area at the end of the eye. The formula is as follows:
[0150] Improvement rate = [(sample 第0天 -sample 第X天 ) / sample 第0天 -(Blank Application Example 第0天 -Blank Application Example 第X天 ) / Blank Application Example 第0天 ]*100%;
[0151] The results obtained are shown in Table 7;
[0152] Table 7
[0153]
[0154] As can be seen from Table 7, the oil-control lotion prepared by the technical solution of the present invention also has excellent moisturizing, repairing and firming effects on the skin, and can be maintained for a long time after discontinuation of use; specifically, the improvement rates of TEWL, F4 and wrinkle area at 28 days are more than 17%, more than 11%, and more than 23%, respectively; the improvement rates of TEWL, F4 and wrinkle area at one week of discontinuation are more than 16%, more than 11%, and more than 23%, respectively;
[0155] It can be seen from Application Examples 1-5 that the mass fractions of component A and component B in the oil control composition will affect the moisturizing, repairing and skin tightening effects of the oil control lotion. When the mass ratio of component A to component B is further selected as (7-9): (1-2), the obtained oil control lotion has an improvement rate of TEWL, F4 and wrinkle area of more than 33%, more than 22% and more than 38% after 28 days; the improvement rate of TEWL, F4 and wrinkle area after one week of discontinuation is more than 32%, more than 21% and more than 37% respectively. It can be seen from Application Examples 1, 6-8 that the mass ratio of the medicinal porphyra extract, the golden camellia extract and the spirulina powder in component A will also affect the product. When the mass ratio of the medicinal porphyra extract, the golden camellia extract and the spirulina powder is further selected as (3-5): (1-3): (1 -3), the obtained oil-control emulsion has improvement rates of TEWL, F4 and wrinkle area of more than 33%, more than 22% and more than 38% respectively at 28 days; the improvement rates of TEWL, F4 and wrinkle area after one week of discontinuation are more than 31%, more than 20% and more than 37% respectively; it can be seen from Application Examples 1 and Application Examples 9-11 that the mass ratio of the green-haired hawkweed extract and the cardamom extract in component B will also affect the product. When the mass ratio of the green-haired hawkweed extract and the cardamom extract is further selected as (1-3):1, the obtained oil-control emulsion has improvement rates of TEWL, F4 and wrinkle area of more than 31%, more than 25% and more than 38% respectively at 28 days; the improvement rates of TEWL, F4 and wrinkle area after one week of discontinuation are more than 31%, more than 23% and more than 37% respectively.
[0156] Finally, it should be noted that the above embodiments are intended to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention may be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.
Claims
1. An oil control composition containing medicinal pore fungi for intelligently improving sebum regulation, characterized in that: The oil control composition comprises component A and component B; The component A comprises a medicinal phytomycetes extract, a golden camellia extract and spirulina powder; The component B comprises a green hawkweed extract and a cardamom extract; In the oil control composition, the mass ratio of component A to component B is component A: component B = (2-20): (0.2-5); In the component A, the mass ratio of the medicinal porphyra extract, the golden camellia extract and the spirulina powder is: the medicinal porphyra extract: the golden camellia extract: the spirulina powder = (1-5): (1-4): (1-4); In the component B, the mass ratio of the Haworthia scabra extract to the Alpinia fasciata extract is Haworthia scabra extract:Alpinia fasciata extract=(1-5):(1-2).
2. The oil control composition according to claim 1, characterized in that In the oil control composition, the mass ratio of component A to component B is component A: component B = (7-9): (1-2).
3. The oil control composition according to claim 1, characterized in that In the component A, the mass ratio of the medicinal porphyra extract, the golden camellia extract and the spirulina powder is: the medicinal porphyra extract: the golden camellia extract: the spirulina powder = (3-5): (1-3): (1-3).
4. The oil control composition according to claim 1, characterized in that In the component B, the mass ratio of the Haworthia scoparia extract to the Alpinia fasciata extract is Haworthia scoparia extract:Alpinia fasciata extract=(1-3):
1.
5. The method for preparing the oil control composition according to any one of claims 1 to 4, characterized in that: The preparation method comprises the following steps: dissolving spirulina powder in deionized water, adding the remaining components and mixing them to obtain an oil control composition.
6. Use of the oil control composition according to any one of claims 1 to 4 in the preparation of a product that promotes the expression of microRNA-29.
7. Use of the oil control composition according to any one of claims 1 to 4 in the preparation of cosmetics.
8. An oil-control lotion, characterized in that: The oil control emulsion comprises the oil control composition according to any one of claims 1 to 4.
9. The oil control emulsion according to claim 8, characterized in that: The oil control emulsion comprises the following components in percentage by mass: 10-25% of the oil control composition according to any one of claims 1 to 4, 1-15% of the cosmetic base, and the balance of deionized water.
10. The oil control emulsion according to claim 9, characterized in that: The cosmetic matrix includes at least one of a thickener, a moisturizer, a pH adjuster, an emulsifier, and a preservative.
11. The oil control emulsion according to claim 10, characterized in that: Contains at least one of the following (a)-(e): (a) the thickener comprises at least one of xanthan gum, carbomer, hydroxyethyl acrylate / sodium acryloyldimethyl taurate copolymer, ammonium acryloyldimethyl taurate / VP copolymer, sclerotium gum, and cetyl alcohol; (b) the moisturizing agent comprises at least one of allantoin, sodium polyacrylate, hydrogenated lecithin, betaine, β-glucan, trehalose, caprylyl glycol, dipropylene glycol, sodium hyaluronate, 1,2-butylene glycol, glycerol, budding pullulan polysaccharide, and ceramide; (c) the pH adjusting agent comprises at least one of arginine, tromethamine, and EDTA-disodium; (d) the emulsifier comprises at least one of caprylic capric triglyceride, C14-22 alcohol, C12-20 alkyl glucoside, cetearyl glucoside, isononyl isononanoate, pentaerythritol tetrastearate, polydimethylsiloxane, stearyl alcohol, hydroxystearic acid, polymethylsilsesquioxane, pentaerythritol distearate, and sucrose stearate; (e) The preservative includes at least one of 1,2-propylene glycol, 1,2-hexanediol and p-hydroxyacetophenone.
12. The method for preparing the oil-control emulsion according to claim 11, characterized in that: The preparation method comprises the following steps: (1) Mix the humectant, thickener and part of the pH adjuster with water, heat to 80-90°C, homogenize at 1000-1400 rpm for 3-5 min, keep warm after homogenization, and obtain prefabricated component A; (2) Mix the emulsifier, heat to 70-80°C, and homogenize at 1000-1400 rpm for 3-5 minutes. After homogenization, keep warm for later use to obtain prefabricated component B; (3) Mix the preservatives and heat to 55-65°C to melt to obtain prefabricated component C; (4) The preformed component A is heated to 75-85°C, and the preformed component B is added at a speed of 200-500 rpm, and stirred and mixed. Then, the temperature is lowered to 55-65°C, and the preformed component C is added at a speed of 200-500 rpm and stirred and mixed. Then, the temperature is lowered to below 45°C, and the oil control composition is added and stirred for 5-10 minutes. Finally, the remaining pH adjuster is added to adjust the pH to 5.5-7.0, and the stirring can be stopped. The material is discharged to obtain an oil control emulsion.
